Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Cleanspark Earnings Perspective: Return On Capital Employed

Benzinga Pro data, Cleanspark (NASDAQ:CLSK) reported Q2 sales of $41.64 million. Earnings fell to a loss of $170.74 thousand, resulting in a 101.18% decrease from last quarter.

Benzinga

comScore's Return on Invested Capital Insights

comScore (NASDAQ:SCOR) brought in sales totaling $93.97 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 421.75%, resulting in a loss of $9.28 million.

Benzinga

Why Vera Bradley Shares Are Sliding Today

Vera Bradley Inc (NASDAQ:VRA) reported a first-quarter FY23 sales decline of 9.7% year-on-year to $98.46 million, missing the consensus of $109.87 million. Adjusted EPS loss of $(0.19) missed the analyst consensus of $(0.16). The gross margin contracted 90 basis points Y/Y to 53.3%. The operating loss for the quarter widened to $(8.2) million.…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Looking Into Antares Pharma's Return On Invested Capital

Benzinga Pro data, Antares Pharma (NASDAQ:ATRS) reported Q1 sales of $41.56 million. Earnings fell to a loss of $2.32 million, resulting in a 107.1% decrease from last quarter.

Benzinga

PLBY Group Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q1, PLBY Group (NASDAQ:PLBY) earned $5.54 million, a 109.89% increase from the preceding quarter. PLBY Group's sales decreased to $69.38 million, a 27.49% change since Q4.

Benzinga

Trade Desk's Return On Capital Employed Insights

Trade Desk (NASDAQ:TTD) brought in sales totaling $315.32 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 281.59%, resulting in a loss of $14.60 million.

Benzinga

Looking Into KnowBe4's Return On Capital Employed

According to Benzinga Pro data KnowBe4 (NASDAQ:KNBE) posted a 69.08% decrease in earnings from Q4. Sales, however, increased by 8.26% over the previous quarter to $75.03 million.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

How AOL And AIM Paved The Way For Apple, iMessage, Twitter And Facebook

Before every cell phone had text messaging and social media platforms like Facebook and Twitter Inc. (NYSE: TWTR) existed, there was AOL Instant Messager, better known as AIM.

Benzinga

Short Volatility Alert: Amazon.com, Inc.

On Tuesday, shares of Amazon.com, Inc. (NASDAQ: AMZN) experienced volatile short activity. After the activity, the stock price went down -1.43% to $123.00. The overall sentiment for AMZN has been Bearish.

Benzinga

Short Volatility Alert: Rezolute, Inc.

On Tuesday, shares of Rezolute, Inc. (NASDAQ: RZLT) experienced volatile short activity. After the activity, the stock price went down -2.59% to $3.01. The overall sentiment for RZLT has been Bearish.

Benzinga

Why Aldeyra Therapeutics' Shares Are Soaring Today?

Aldeyra Therapeutics Inc's (NASDAQ:ALDX) Phase 3 TRANQUILITY-2 trial of reproxalap for dry eye disease has achieved the primary endpoint. Reproxalap was statistically superior to the vehicle for each of the two prespecified primary endpoints, Schirmer test and ≥10 mm Schirmer test responder proportions after a single day of dosing. The Schirmer test,…

Benzinga

Why Stealth BioTherapeutics Shares Are Surging Today?

Stealth BioTherapeutics Corp (NASDAQ:MITO) presented new SBT-272 preclinical data demonstrating functional improvement in upper motor neurons with TDP-43 pathology. TDP-43 pathology plays a significant role in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The data were presented at the Keystone Neurodegeneration Symposium. A Phase 1 study to evaluate the safety and tolerability…

Benzinga

Why Heartcore Enterprises Shares Are Soaring Today

Heartcore Enterprises, Inc (NASDAQ:HTCR) board approved a share buyback of $3.5 million. Heartcore held $13.9 million in cash and equivalents as of March 31 and used $2.4 million in operating cash flow. CEO Sumitaka Yamamoto said, "With the continuous growth of our core CMS and Digital Transformation businesses, supplemented by our latest Go IPO consulting…

Benzinga

Microsoft Goes Aggressive In Its Protest Against Russia's Ukraine Invasion - Read How

In an email accessed by Bloomberg, Microsoft Corp (NASDAQ:MSFT) disclosed materially scaling down its operations in Russia following the Russian invasion of Ukraine. Microsoft joined the likes of International Business Machines Corp (NYSE:IBM) and Apple Inc (NASDAQ:AAPL), cutting back or exiting the country after the invasion. The scaling down will affect over 400 employees. “As a result…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Rigel Pharmaceuticals' Fostamatinib Flunks In Late-Stage Rare Blood Disorder Trial

Rigel Pharmaceuticals Inc (NASDAQ: RIGL) shares are falling on disappointing data from the FORWARD Phase 3 trial of fostamatinib in patients with warm autoimmune hemolytic anemia (wAIHA).

Benzinga

Russia Imposes New Sanctions That Include Netflix, BlackRock, Delta Air Lines Chiefs

Russia retaliated against U.S. sanctions by imposing its own on multiple prominent American CEOs, including BlackRock, Inc (NYSE:BLK), Delta Air Lines, Inc (NYSE:DAL), Netflix, Inc (NASDAQ:NFLX), and Comcast Corp (NASDAQ:CMCSA) Universal Pictures, the Wall Street Journal reports. The sanction included U.S. administration officials and former heads of other large U.S. corporations, and executives at rating firms operated by S&P Global…

Benzinga

Is Netflix Exploring Acquisition Opportunities? Why Roku Stock Is Surging

Roku Inc (NASDAQ: ROKU) shares are trading higher Wednesday following a Business Insider report suggesting the company may be in talks to be acquired by Netflix

Benzinga

Immunovant To Start Pivotal Batoclimab Trials In Thyroid Eye Disease Later This Year

Immunovant Inc (NASDAQ:IMVT) has aligned with the FDA Division of Ophthalmology on plans to initiate two placebo-controlled Phase 3 trials to evaluate batoclimab in thyroid eye disease (TED). Immunovant expects to initiate its Phase 3 TED program in 2H of 2022 and is expected to enroll about 100 subjects for each trial. Topline…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Q1 Miss, FY22 Outlook Cut, CFO Departure: Lots Going On With Ollie's Bargain Outlet

Ollie's Bargain Outlet Holdings Inc (NASDAQ:OLLI) reported a first-quarter FY22 sales decline of 10.1% year-on-year to $406.67 million, missing the consensus of $417.24 million. Comparable store sales decreased 17.3% in Q1 versus an 18.8% increase last year. Gross profit fell 22.6% Y/Y to $141.3 million, with the margin contracting 560 basis points to…

Benzinga

Expert Ratings for Plug Power

Plug Power (NASDAQ:PLUG) has observed the following analyst ratings within the last quarter:

Benzinga

What 7 Analyst Ratings Have To Say About The RealReal

Analysts have provided the following ratings for The RealReal (NASDAQ:REAL) within the last quarter:

Benzinga

Amazon To Cease Gig Economy Delivery Service In Second Largest Market

Amazon.com Inc (NASDAQ: AMZN) looks to shut down its gig economy delivery service in Germany, its second-largest market after the U.S., for undisclosed reasons,

Benzinga

Moderna's Updated COVID-19 Shot Boosts Omicron Protection

Moderna Inc (NASDAQ: MRNA) has

Benzinga

The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Why Cyren Stock Is Soaring Today

CYREN Ltd (NASDAQ: CYRN) shares are trading higher Wednesday after the company entered into an agreement with Content Services Group to sell all equity interests in its legacy secure email gateway business.

1 … 416 417 418 419

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Amyotrophic lateral sclerosis

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.